Brief: Novo Nordisk Says All Regulatory Closing Conditions Relating To Review Of Novo Holdings A/S's Pending Acquisition Of Catalent Have Been Fulfilled
14/12/2024 05:12
Dec 14 (Reuters) - Novo Nordisk NOVOb.CO :
* NOVO NORDISK: ALL REGULATORY CLOSING CONDITIONS RELATING
TO
REVIEW OF NOVO HOLDINGS A/S'S PENDING ACQUISITION OF CATALENT
HAVE BEEN FULFILLED
* NOVO NORDISK: PARTIES ARE NOW FREE TO CLOSE TRANSACTION AS
WELL
AS NOVO NORDISK'S SUBSEQUENT ACQUISITION OF 3 CATALENT
MANUFACTURING SITES FROM NOVO HOLDINGS
* NOVO NORDISK: FOR 2025, ACQUISITION IS EXPECTED TO HAVE A
MID
SINGLE-DIGIT NEGATIVE IMPACT ON OPERATING PROFIT GROWTH
* NOVO NORDISK: ACQUISITION WILL BE MAINLY DEBT-FINANCED,
WITH
INTEREST PAYMENTS NEGATIVELY IMPACTING NET FINANCIAL ITEMS
* NOVO NORDISK: NOT EXPECTING TO INITIATE A SHARE BUYBACK
PROGRAMME IN 2025
Source text: ID:nGNE8XVhg0
Further company coverage: CTLT.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Catalent
See all newsBrief: Novo Holdings Completes Acquisition Of Catalent
Novo Nordisk rises as Catalent deal in US nears
Regulatory conditions on Novo Holdings' $16.5 bln Catalent deal fulfilled, companies say
Brief: Catalent And Novo Holdings Fulfill All Regulatory Closing Conditions For Pending Transaction
Brief: Novo Nordisk Says All Regulatory Closing Conditions Relating To Review Of Novo Holdings A/S's Pending Acquisition Of Catalent Have Been Fulfilled